Clonidine-Displacing Substance and Its Putative Role in Control of Insulin Secretion: A Minireview
- 31 October 1998
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 31 (4) , 525-529
- https://doi.org/10.1016/s0306-3623(98)00052-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bedEuropean Journal of Pharmacology, 1996
- The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1‐ and I2‐sitesBritish Journal of Pharmacology, 1994
- Role of α2-Adrenoceptors and Imidazoline-Binding Sites in the Control of Insulin SecretionClinical Science, 1993
- Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080British Journal of Pharmacology, 1993
- Polyclonal anti-idazoxan antibodies: characterization and purificationEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Stimulation of insulin secretion by the imidazoline α2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding siteEuropean Journal of Pharmacology, 1993
- Clonidine-displacing substance (CDS) and its putative imidazoline receptor: New leads for further divergence of α2-adrenergic receptor activityBiochemical Pharmacology, 1991
- Stimulation of insulin secretion by efaroxan may involve interaction with potassium channelsEuropean Journal of Pharmacology, 1990
- An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressureEuropean Journal of Pharmacology, 1986
- Isolation of an endogenous clonidine‐displacing substance from rat brainFEBS Letters, 1984